logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

JXR (01951) repurchased 2.1895 million shares on November 19 for HK$4.855 million.

date
19:16 19/11/2026
avatar
GMT Eight
JXR (01951) announced that on November 19, 2026, it spent HK$4.855 million to repurchase 2.1895 million shares.
JXR (01951) announced that on November 19, 2026, it repurchased 2.1895 million shares for HK$4.855 million.
Related Articles
China Stock
Yinchuan Xinhua Commercial (600785.SH) has cumulatively repurchased 8.85% of its shares, spending approximately RMB300 million.
HK Stock
GRAND PHARMA (00512): Globally Innovative Nebulized Inhalant GPN01564 for the Treatment of Respiratory Syncytial Virus Approved to Initiate Phase I Clinical Study
China Stock
Aotop Technology (688845.SH) IPO priced at RMB18.18 per share, subscription opens on November 23.
Yinchuan Xinhua Commercial (600785.SH) has cumulatively repurchased 8.85% of its shares, spending approximately RMB300 million.
China Stock
GRAND PHARMA (00512): Globally Innovative Nebulized Inhalant GPN01564 for the Treatment of Respiratory Syncytial Virus Approved to Initiate Phase I Clinical Study
HK Stock
Aotop Technology (688845.SH) IPO priced at RMB18.18 per share, subscription opens on November 23.
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.